At the same time, a study has found that the JAK-STAT pathway might lead to left atrial fibrosis, which indicates that JAK-STAT pathway inhibitors, such as S3I-201, may become a new therapeutic approach for AF. This evidence concerns the gene SOAT1 and atrial fibrillation.